Health-related quality of life and adverse events during 14 days after receiving a live-attenuated influenza vaccine in Japanese children 4-15 years of age. [PDF]
Di Lorenzo A +5 more
europepmc +1 more source
Nasal spray live attenuated influenza vaccine: the first experience in Italy in children and adolescents during the 2020-21 season. [PDF]
Gasparini C +10 more
europepmc +1 more source
Systematic review of evidence on feasibility of administering intranasal live attenuated influenza vaccine at home. [PDF]
Jhaveri R, Skolnik N, Bandell A.
europepmc +1 more source
Safety and Efficacy of Spray Intranasal Live Attenuated Influenza Vaccine: Systematic Review and Meta-Analysis. [PDF]
Perego G +8 more
europepmc +1 more source
Expert opinion on improving influenza vaccination coverage rate in Qatar: Strategic solutions and role of live attenuated influenza vaccine (LAIV). [PDF]
Al-Maslamani M +11 more
europepmc +1 more source
Live attenuated influenza vaccine with low proportions of defective interfering particles elicits robust immunogenicity and cross-protection. [PDF]
Wu M +21 more
europepmc +1 more source
Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccine. [PDF]
Marriott AC +11 more
europepmc +1 more source
Studying Early Life Live-Attenuated influenza virus immune Responses (STELLAR): study protocol for an exploratory observational study of the nasal mucosal and systemic immune response in healthy children given an intranasal live-attenuated influenza vaccine. [PDF]
Kelleher K +18 more
europepmc +1 more source
Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges. [PDF]
Lee AC +12 more
europepmc +1 more source

